Cargando…
Selective homing of CAR-CIK cells to the bone marrow niche enhances control of the acute myeloid leukemia burden
Acute myeloid leukemia (AML) is a hematological malignancy derived from neoplastic myeloid progenitor cells characterized by abnormal clonal proliferation and differentiation. Although novel therapeutic strategies have recently been introduced, the prognosis of AML is still unsatisfactory. So far, t...
Autores principales: | Biondi, Marta, Tettamanti, Sarah, Galimberti, Stefania, Cerina, Beatrice, Tomasoni, Chiara, Piazza, Rocco, Donsante, Samantha, Bido, Simone, Perriello, Vincenzo Maria, Broccoli, Vania, Doni, Andrea, Dazzi, Francesco, Mantovani, Alberto, Dotti, Gianpietro, Biondi, Andrea, Pievani, Alice, Serafini, Marta |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The American Society of Hematology
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10646802/ https://www.ncbi.nlm.nih.gov/pubmed/36787509 http://dx.doi.org/10.1182/blood.2022018330 |
Ejemplares similares
-
IL-3-zetakine combined with a CD33 costimulatory receptor as a dual CAR approach for safer and selective targeting of AML
por: Perriello, Vincenzo Maria, et al.
Publicado: (2022) -
Catch me if you can: how AML and its niche escape immunotherapy
por: Tettamanti, Sarah, et al.
Publicado: (2021) -
Engineering tandem CD33xCD146 CAR CIK (cytokine-induced killer) cells to target the acute myeloid leukemia niche
por: Alberti, Gaia, et al.
Publicado: (2023) -
Acute myeloid leukemia shapes the bone marrow stromal niche in vivo
por: Pievani, Alice, et al.
Publicado: (2020) -
Location First: Targeting Acute Myeloid Leukemia Within Its Niche
por: Pievani, Alice, et al.
Publicado: (2020)